Ordeniza, Lexie Zane Y.

HRN: 21-35-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2022
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
06/03/2022
06/03/2022
TOPICAL, EYE
Ou
Od
Ophthalmic Prevention
Waiting Final Action 
10/17/2022
CEFUROXIME 1.5GM (VIAL)
10/17/2022
10/23/2022
IV
150mg
Q8
PCAP
Waiting Final Action 
10/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2022
10/23/2022
IV
53mg
Q8
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: